These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38563434)

  • 1. Demographic and Clinical Features and Factors Affecting the Quality of Life of Patients With Hidradenitis Suppurativa: A Cross-sectional Study.
    Erol Mart HM; Bostanci S; Caliskan Odabas D
    Dermatol Surg; 2024 Jul; 50(7):630-635. PubMed ID: 38563434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
    Johnston L; Dupuis E; Lam L; Poelman S
    J Cutan Med Surg; 2023; 27(5):487-492. PubMed ID: 37489915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?
    Pavon Blanco A; Turner MA; Petrof G; Weinman J
    Br J Dermatol; 2019 Feb; 180(2):338-345. PubMed ID: 30171696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting quality of life in patients with hidradenitis suppurativa.
    Jørgensen AR; Holm JG; Ghazanfar MN; Yao Y; Ring HC; Thomsen SF
    Arch Dermatol Res; 2020 Aug; 312(6):427-436. PubMed ID: 31848682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life in Cohabitants of Patients with Hidradenitis Suppurativa: A Cross-sectional Study.
    Ramos-Alejos-Pita C; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in patients with hidradenitis suppurativa.
    Onderdijk AJ; van der Zee HH; Esmann S; Lophaven S; Dufour DN; Jemec GB; Boer J
    J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):473-8. PubMed ID: 22339940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG).
    Grimstad Ø; Tzellos T; Dufour DN; Bremnes Ø; Skoie IM; Snekvik I; Jarnaess E; Kyrgidis A; Ingvarsson G
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1164-1171. PubMed ID: 30451320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.
    Li Y; Speck P; Viera E; Siira M; Orenstein LAV
    Dermatology; 2023; 239(6):1007-1012. PubMed ID: 37717562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study.
    Alavi A; Anooshirvani N; Kim WB; Coutts P; Sibbald RG
    Am J Clin Dermatol; 2015 Feb; 16(1):61-5. PubMed ID: 25432664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical symptoms and psychosocial problems associated with hidradenitis suppurativa: correlation with Hurley stage.
    McKenzie SA; Harview CL; Truong AK; Grogan TR; Shi VY; Bennett RG; Hsiao JL
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Three-Item Skindex-Mini Among Hidradenitis Suppurativa Patients With Diverse Racial Backgrounds.
    Orenstein LAV; Amah A; Shaw FM; Zhang C; Swerlick RA; Chen SC
    J Cutan Med Surg; 2020; 24(5):457-460. PubMed ID: 32469259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.